PMID: 11918469Mar 29, 2002Paper

Progressive myoclonic epilepsies

Journal of Child Neurology
Joan A Conry

Abstract

The progressive myoclonic epilepsies are a rare but extremely debilitating group of disorders that are difficult to diagnose and even harder to treat. They represent a heterogeneous subgroup of those with secondary generalized epilepsy. Efficacy of treatment is often measured in terms of slowing a patient's inevitable decline. Reviewed here are the classification of progressive myoclonic epilepsies, features of myoclonic seizures, the five most prevalent progressive myoclonic epilepsy syndromes-Unverricht-Lundborg disease, myoclonus epilepsy with ragged red fibers (MERRF) mitochondrial disease, Lafora's disease, neuronal ceroid lipofuscinoses, and sialidoses-and current treatment options.

References

Jan 1, 1986·Clinical Neuropharmacology·J A ObesoJ M Martínez Lage
Jun 1, 1988·Neurology·T R HenryM Jacobs
Feb 26, 1998·Epilepsy Research·M Kyllerman, E Ben-Menachem
Sep 11, 2001·Neurology·K E WisniewskiM Philippart

❮ Previous
Next ❯

Citations

May 18, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Leo L ChanKenneth L Watkin
Feb 15, 2016·Social Science & Medicine·Staffan Bengtsson, Pia H Bülow
Mar 22, 2005·Lancet Neurology·Amre ShahwanNorman Delanty
Jul 2, 2010·The Neurologist·Deivasumathy Muthugovindan, Adam L Hartman
Dec 6, 2005·Forensic Science International : Synergy·Regula Wick, Roger W Byard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.